Evrofarma S.A.
EVROF.AT
Get informed when a big investor buys or sells
+ FollowMarket Cap$52.89M
Close$
$7.63
97.1% upside
Current Fair Value
97.1% upsideUndervalued by 97.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $52.89 Million |
|---|---|
| Enterprise Value | $65.27 Million |
| Dividend Yield | $0.06 (3.03%) |
| Earnings per Share | $0.26 |
| Beta | 0.71 |
| Outstanding Shares | 13,668,763 |
Return
| Return on Equity | 22.29% |
|---|---|
| Return on Assets | 8.29% |
| Return on Invested Capital | 13.48% |
Valuation & Multiples
| P/E Ratio | 10.09 |
|---|---|
| PEG | -36.05 |
| Price to Sales | 0.97 |
| Price to Book Ratio | 3.87 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | 9.99 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 0.77 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Evrofarma S.A.
178 employees
CEO: Paschalis H. Papazilakis Evrofarma SA produces and sells dairy products in Greece. It sells milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.